| 000 | 01111 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516232821.0 | ||
| 264 | 0 | _c20160606 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a0946-1965 | ||
| 024 | 7 |
_a10.5414/CP202129 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHsu, Li-Feng | |
| 245 | 0 | 0 |
_aA statistical analysis to assess the most critical bioequivalence parameters for generic liposomal products. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology and therapeutics _cDec 2014 |
||
| 300 |
_a1071-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aDrugs, Generic _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLiposomes |
| 650 | 0 | 4 |
_aMononuclear Phagocyte System _xmetabolism |
| 650 | 0 | 4 | _aMonte Carlo Method |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 700 | 1 | _aHuang, Jin-Ding | |
| 773 | 0 |
_tInternational journal of clinical pharmacology and therapeutics _gvol. 52 _gno. 12 _gp. 1071-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5414/CP202129 _zAvailable from publisher's website |
| 999 |
_c24177587 _d24177587 |
||